No Data
No Data
Ruvidar(TM) Proven More Effective Than Acyclovir in Destruction of Herpes Simplex Virus
Theralase Technologies Inc. (TLTFF) Q2 2024 Earnings Call Transcript Summary
Theralase(R) Demonstrates Unique Ability to Activate Rutherrin(R) With Diabetes Drug
Theralase(R) Release's 2Q2024 Financial Statements
Rutherrin(R) Demonstrates Complete Response in Lung Cancer Preclinically
Reminder Notice of Annual General and Special Meeting for Shareholders of Theralase(R)
No Data